- Previous Close
68.50 - Open
69.00 - Bid 68.40 x 49300
- Ask 69.10 x 22000
- Day's Range
68.30 - 69.10 - 52 Week Range
47.15 - 70.00 - Volume
5,957 - Avg. Volume
44,137 - Market Cap (intraday)
1.18B - Beta (5Y Monthly) 0.89
- PE Ratio (TTM)
44.06 - EPS (TTM)
1.55 - Earnings Date Mar 3, 2025 - Mar 7, 2025
- Forward Dividend & Yield 0.22 (0.32%)
- Ex-Dividend Date May 16, 2024
- 1y Target Est
69.64
Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospital information systems and integrated diagnostic modules that cover various functional requirements of hospitals, psychiatric institutions, rehabilitation facilities, and diagnostic centers, as well as nursing homes. The company also provides IT services comprising integrated solutions; radiology and VNA solutions consisting of radiology information system, vendor neutral archive, PACS, teleradiology portal, telemedicine portal, referral portal, patient portal for images and diagnostic findings, webviewer, telemedicine networking, and DICOM RT-viewer; and residential and psychiatry solutions. The company serves its customers through its own sites, as well as certified dealers. NEXUS AG was founded in 1989 and is headquartered in Donaueschingen, Germany.
www.nexus-ag.de1,980
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NXU.DE
View MorePerformance Overview: NXU.DE
Trailing total returns as of 1/3/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NXU.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NXU.DE
View MoreValuation Measures
Market Cap
1.18B
Enterprise Value
1.09B
Trailing P/E
44.19
Forward P/E
30.67
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.53
Price/Book (mrq)
4.45
Enterprise Value/Revenue
4.18
Enterprise Value/EBITDA
18.35
Financial Highlights
Profitability and Income Statement
Profit Margin
10.09%
Return on Assets (ttm)
5.08%
Return on Equity (ttm)
10.21%
Revenue (ttm)
265.36M
Net Income Avi to Common (ttm)
26.77M
Diluted EPS (ttm)
1.55
Balance Sheet and Cash Flow
Total Cash (mrq)
112.12M
Total Debt/Equity (mrq)
7.54%
Levered Free Cash Flow (ttm)
14.8M